The Asia Pacific mycoplasma testing market was worth USD 118.12 Million in 2018 and is estimated to be growing at a CAGR of 16.7%, to reach USD 255.67 Million by 2023. Mycoplasma are the simplest and smallest microorganisms till date and they are self-replicating too. They do not possess a complete set of genetic material and hence they cannot conduct certain functions such as synthesis of amino acids and cell wall generation.

The cells contaminated by mycoplasma go unnoticed most of the time. They do not cause observable changes after contamination in a cell culture such as change in turbidity and pH. Also, due to their small size they cannot be detected by a light microscope. However, they showcase virulent effects on eukaryotic cells such as altering protein synthesis, cellular metabolism etc. Hence, mycoplasma testing has become essential in cell culture research laboratories.

Increasing investments for life sciences research, rising number of pharma and biotech industries due to the increase in government funding for R&D in drug development and new technological advancements in mycoplasma testing methods are expected to propel the market in the given forecast period. However, factors such as inflexible government regulations and excessive costs involved with mycoplasma testing methods are inhibiting the growth of the market.

The Asia-Pacific mycoplasma testing market is segmented on the basis of product, technique, application, end user and region. On the basis of product, the market is segmented into kits & reagents, instruments and services. Kits & reagent is expected to hold the largest market share in this segment. This is due to the requirement for repeated purchase of these products as they are consumed with each test while instruments need not be purchased frequently. Based on technique, the market is segmented into PCR, ELSA, Direct Assays, Indirect Assays, Microbial culture techniques, Enzymatic Methods, and DNA Staining. PCR technique is projected to lead the market in this segment as it is highly accepted in life sciences research due to the speed and flexibility of this technique. Based on application, the mycoplasma testing market is segmented into Cell Line Testing, Virus Testing, End-Of-Production Cell Testing and other applications. Cell line testing is expected to lead the market and is also one of the rapidly growing segments due to the increasing application of cell line testing in research as well as biopharmaceutical production. Based on end user, the market is segmented into Pharmaceutical Companies, Contract research organizations, Academic Research Institutes and Cell Banks. Pharmaceutical companies segment holds the largest market share due to the increasing R&D activities in pharmaceutical and biotechnology companies.

The mycoplasma testing market in Asia-Pacific is segmented into China, India, Japan, Australia and South Korea based on the region. Asia-Pacific is the fastest growing market for mycoplasma testing due to the increase in number of pharmaceutical and biotechnology industries and thriving trend of pharmaceutical outsourcing to this region.

Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development

A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market